OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
July 01, 2013
From the Editor
Pharma and biotech companies, with the rest of the healthcare industry, must face change.
Industry experts discuss the implementation of QbD and PAT tools in biopharmaceutical manufacturing.
European governments are under pressure to take regulatory action, but solving the problem of medicine shortages is not as straightforward as it seems.
Boot Camp Business Guide
Five key attributes to look for in a biopharm training partner.
Brazil offers opportunities and challenges for global pharmaceutical companies.
Perspectives on Outsourcing
The industry may not be ready for India and China as regulatory issues emerge.
Analytical Best Practices
The author discusses the need for stability analysis.
An analytical method assesses the effects of media condition on cultured antibodies.
Increased manufacturer outsourcing requires clear policies and written agreements with CMOs.
Burrill on Biotech
Biotech companies raise most money in 13 years.
Traditional project decision-making vs. a QbD approach.
Click the title above to open the BioPharm International July 2013 issue in an interactive PDF format.